Login / Signup

Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.

Parul TandonEugenia Y LeeCynthia MaxwellLara HitzLindsy AmbrosioLevinus DielemanBrendan HalloranKaren KroekerVivian Wai-Mei Huang
Published in: Digestive diseases and sciences (2020)
Fecal calprotectin may be a useful noninvasive marker to predict adverse pregnancy-related outcomes in patients with IBD.
Keyphrases
  • patients with inflammatory bowel disease
  • preterm birth
  • pregnancy outcomes
  • disease activity
  • type diabetes
  • adverse drug
  • glycemic control
  • weight loss
  • electronic health record